๐—ฅ๐—ถ๐—ฝ๐˜ ๐—ก๐—ฒ๐˜„๐˜€ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฎ ๐—œ๐—ฟ๐—ฒ๐—น๐—ฎ๐—ป๐—ฑ ๐Ÿ”‰๐ŸŒ RT
1.14K subscribers
144K photos
8.76K videos
352 files
180K links
Support Me For My Work.. โค๏ธ https://www.buymeacoffee.com/OffgridIreland Russia Today Feed
Download Telegram
Dr. Marcus De Brun (Twitter)

The vaccine is almost two years old.

Anyone out there know what SARS-CoV-2 has been doing over the past 2 years?

Or has evolution become a conspiracy theory as well?
News For All Ireland (Telegram)

A power that only the people to get her can get back.

Legislation allowing for restrictions on indoor hospitality will be kept in place for another three months as a โ€œsafety netโ€ in case something happens with Covid-19 during the winter, Minister for Health Stephen Donnelly has said.

He told the Dรกil that Ireland is on course to remove existing restrictions on October 22nd based on 90 per cent, or close to that figure, of people aged 16 or over being fully vaccinated.
News For All Ireland (Telegram)

Building your immune system naturally is just a conspiracy.

The HSE is urging the public to get a flu vaccine this winter amid concerns over a more โ€œsevere flu season this yearโ€.

Director of the HSEโ€™s National Immunisation Office Dr Lucy Jessop, said practices such as masks wearing, travel restrictions and social distancing which have protected the public against Covid-19, also protected people from seasonal flu last year.

She said this could lead to flu circulating more widely in the community in the coming months.
News For All Ireland (Telegram)

International tourists will not be welcomed back to Australia until next year, with the return of skilled migrants and students given higher priority, the prime minister said.

Prime Minister Scott Morrison said Australia was expected to reach the benchmark of 80% of the population aged 16 and older having a second dose.
Likewise, mass vaccination campaigns may have a beneficial short-time effect in that they reduce viral spread and protect vulnerable people from disease (e.g., elderly people and those with underlying disease), but will eventually drive the propagation of more infectious variants. Dominant circulation of the latter will lead to a resurgence of viral infectious pressure, thereby eroding the innate immune defense of the unvaccinated (i.e., mostly younger age groups including children) and thus making them more susceptible to contracting Covid-19 disease. This already explains why mass vaccination campaigns conducted in the middle of a pandemic will only cause Sars-CoV-2 to engender more disease and claim more human lives. Because of this mass vaccination program, waves of morbidity will continue for much longer, as more (recovery from) disease cases will be required to compensate for the erosion of the populationโ€™s innate immunity and, therefore, to make up for the latterโ€™s deficient contribution to HI.


When one considers that all of these effects, whether beneficial or detrimental, will mutually interfere and that the average of population segments that are adversely or favorably affected by the overall impact of this multifactorial phenomenon will shift over time, it can become very complex and challenging to elucidate whether any single human influence has a beneficial or detrimental impact. It all depends on what โ€˜endpointโ€™ (e.g., protection against infection versus protection against disease) one is looking at in which part of the population at which stage of the pandemic and within which environmental context. On the other hand, the extent of infection-prevention measures, the distribution of vaccine coverage rates and the time point of emergence of new dominant circulating variants and their level of infectiousness may dramatically differ between countries/ regions and so will the corresponding โ€˜snapshotโ€™ results recorded for a particular country/ region.


This is why experts currently look at the impact of mass vaccination campaigns either as at a glass that is half full (โ€˜the vaccines workโ€™!) or one that is half empty (โ€˜the vaccines donโ€™t work well enoughโ€™). That is precisely THE issue: A vaccine that only prevents hospitalizations and severe Covid-19 disease is not good enough to be used to combat a pandemic. From a global or even public health perspective, these are, therefore, not the right criteria to evaluate the success of mass vaccination campaigns deployed during a pandemic. Using these criteria as an indicator of the level of control over the pandemic will inevitably lead to a further escalation of this morbidity and mortality rates. There should be no doubt that non-transmission-blocking vaccines (i.e., so-called โ€˜leakyโ€™ or โ€˜imperfectโ€™ vaccines) can never ever control a pandemic, even though they may temporarily protect against disease. Only temporarily? Yes, indeed. Given the globally increasing immune pressure and concomitant infectious viral pressure, genomic epidemiologists have no doubt that this pandemic roller coaster will not stop before it takes us over the cliff into the abyss of complete viral resistance to anti-spike (S) antibodies. That is where all runaway trains of the different ongoing pandemics of highly infectious variants will be coming together and converge into a big whirl where they can no longer be distinguished from one another. The first stages of this evolution is what we now begin to see in countries which have already massively vaccinated their population (e.g., Israel). There is no doubt that other countries like the United Kingdom and the United States will soon go down the same path. Due to increasing resistance to neutralizing anti-S antibodies (Abs), these countries are now even beginning to shift from a primarily beneficial (i.e., less susceptible to severe disease) to a primarily detrimental effect (more susceptible to severe disease) in the vaccinated as compared to the unvaccinated